文献速递胸部肿瘤支持与姑息治疗

肺癌公众、肿瘤科医生与患者态度及污名化十年横断面分析

A 10-Year Cross-Sectional Analysis of Public, Oncologist, and Patient Attitudes About Lung Cancer and Associated Stigma.
PubMed 文献 · J Thorac Oncol · 2020-10-01

该研究在2008年和2018年采用相同问卷和方法,对公众、肿瘤科医生和肺癌患者进行横断面调查,比较对肺癌及污名化的态度变化。结果显示公众对肺癌认知从82.5%升至94%(p<0.0001),但认为患者至少部分应受责备的比例仍达60.3%;患者感知污名从54.5%升至72.1%(p<0.001),感知被区别对待从50.8%升至69.4%(p<0.001)。

要点

  • 公众肺癌认知率从82.5%升至94%(p<0.0001),但责备患者比例仍高(60.3%)。
  • 患者感知肺癌污名从54.5%升至72.1%(p<0.001)。
  • 患者感知被社会区别对待从50.8%升至69.4%(p<0.001)。

核心结论

  • 尽管治疗选择和疾病认知有所改善,肺癌污名化仍是一个显著问题,且患者自报污名感意外增加。

研究设计与样本

  • 采用相同工具和方法,间隔10年(2008年和2018年)对公众、肿瘤科医生和肺癌患者进行横断面调查。
  • 2018年共纳入1001名公众、205名肿瘤科医生和208名肺癌患者。

主要发现

  • 公众对肺癌的认知率从2008年的82.5%升至2018年的94%(p<0.0001)。
  • 2018年公众中认为肺癌患者至少部分应受责备的比例为60.3%,与2008年相比无变化。
  • 2018年更多肺癌患者同意存在与肺癌相关的污名(72.1% vs 54.5%,p<0.001)。
  • 2018年更多肺癌患者同意被诊断者受到社会区别看待或对待(69.4% vs 50.8%,p<0.001)。

临床怎么用

  • 临床沟通中应关注肺癌患者感知到的污名,主动评估并干预以减少其心理负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer stigma negatively impacts the clinical care and outcomes of those diagnosed, resulting in enduring disparities. The objective of this study was to determine whether attitudes toward lung cancer and the stigmatization of people diagnosed have changed over a decade. METHODS: A cross-sectional survey was administered to the general public, oncologists, and people with lung cancer 10 years apart (2008 and 2018) using the same instrument and methodology. The measures of stigma agreement ratings on a five-point Likert scale were compared between 2008 and 2018 for all three sample groups. RESULTS: In 2018, a total of 1001 members of the general public, 205 oncologists, and 208 people with lung cancer were enrolled. Improvements were noted over the decade, including the availability of more treatment options. Greater disease awareness was also found, with 94% of the public reporting knowledge of lung cancer (versus 82.5% in 2008, p < 0.0001). However, no change was found in the percentage of the public reporting that patients with lung cancer are at least partially to blame for their illness (60.3% in 2018). In 2018, more people with lung cancer agreed there is a stigma associated with lung cancer (72.1 versus 54.5%, p < 0.001) and that those diagnosed are viewed or treated differently by society in general (69.4% versus 50.8%, p < 0.001). CONCLUSIONS: The results reflect recognition of treatment gains and increased visibility of lung cancer but also highlight that stigma remains a significant problem. Of critical importance to the care of those diagnosed was the unexpected increase in stigma reported by the patient population.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Rigney M, Rapsomaniki E, Carter-Harris L, et al. A 10-Year Cross-Sectional Analysis of Public, Oncologist, and Patient Attitudes About Lung Cancer and Associated Stigma. J Thorac Oncol. 2020. PMID: 33011390. doi:10.1016/j.jtho.2020.09.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。